Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial.

Autor: CRASH Trial Collaborators (CORPORATE AUTHOR), Roberts, Ian (AUTHOR), Yates, David (AUTHOR), Sandercock, Peter (AUTHOR), Farrell, Barbara (AUTHOR), Wasserberg, Jonathan (AUTHOR), Lomas, Gabrielle (AUTHOR), Cottingham, Rowland (AUTHOR), Svoboda, Petr (AUTHOR), Brayley, Nigel (AUTHOR), Mazairac, Guy (AUTHOR), Laloë, Véronique (AUTHOR), Muñoz-Sánchez, Angeles (AUTHOR), Arango, Miguel (AUTHOR), Hartzenberg, Bennie (AUTHOR), Khamis, Hussein (AUTHOR), Yutthakasemsunt, Surakrant (AUTHOR), Komolafe, Edward (AUTHOR), Olldashi, Fatos (AUTHOR), Yadav, Yadram (AUTHOR)

Publikováno v: Lancet. 10/9/2004, Vol. 364 Issue 9442, p1321-1328. 8p.

Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months.

Autor: Edwards P, Arango M, Balica L, Cottingham R, El-Sayed H, Farrell B, Fernandes J, Gogichaisvili T, Golden N, Hartzenberg B, Husain M, Ulloa MI, Jerbi Z, Khamis H, Komolafe E, Laloë V, Lomas G, Ludwig S, Mazairac G, Muñoz Sanchéz Mde L, Nasi L, Olldashi F, Plunkett P, Roberts I, Sandercock P, Shakur H, Soler C, Stocker R, Svoboda P, Trenkler S, Venkataramana NK, Wasserberg J, Yates D, Yutthakasemsunt S

Publikováno v: Lancet (London, England) [Lancet] 2005 Jun 4-10; Vol. 365 (9475), pp. 1957-9.